An exciting opportunity exists to join the Western Sydney University Translational Health Research Institute (THRI) as an Associate Research Fellow, to work with an experienced team of researchers addressing LGBTI experiences of cancer survivorship and care.
The ‘Out with Cancer’ project is funded through an Australian Research Council Linkage Project Grant in partnership with the Prostate Cancer Foundation of Australia (PCFA), New South Wales Cancer Council (NSWCC), CanTeen, National LGBTI Health Alliance, ACON and Breast Cancer Network Australia (BCNA).
The project will utilise a range of creative and innovative methodologies, including visual methods, interviews and surveys, and an intersectional theoretical framework, to examine the perspectives of cancer survivors, their carers, and professional stakeholders, and develop targeted resources and recommendations for culturally competent cancer care and policy.
The successful applicant will work as part of a team, facilitating data collection, analysis and dissemination of the findings of the ‘Out with Cancer’ project. The appointee will also work on ongoing projects within THRI (such as women’s reproductive health and CALD health), as well as collaborate on funding applications for future projects.
To find more about this opportunity, please review the position description. While this is a full-time position, flexible and part-time arrangements will be considered for the suitable applicant.
Remuneration package: Academic Level A $93,019 to $112,381 per annum (comprising $78,602 to $94,963 pa, 17 % Superannuation and Leave Loading)
Enquiries: Professor Jane Ussher ([email protected])
Closing date: 23 September 2018
Disclaimer: Psychreg is mainly for information purposes only. Materials on this website are not intended to be a substitute for professional advice, diagnosis, medical treatment, or therapy. Never disregard professional psychological or medical advice nor delay in seeking professional advice or treatment because of something you have read on this website. Read our full disclaimer here.